Title of Collaborative Activity: |
Gynecologic Cancer Steering Committee Clinical Trials Planning Meeting: Defining and Targeting Molecular Pathways to Direct Personalized Value-added Treatments for Patients with Epithelial Ovarian Cancer - February 25-26, 2021 |
Description of Collaborative Activity: |
The meeting objectives were to (1) define current and emerging molecular and clinical classifications of epithelial ovarian cancer subgroups and subsequent implications for trial design and eligibility; (2) design clinical trials that will explore new hypotheses needed to drive targeted treatment approaches in epithelial ovarian cancer; (3) incorporate novel trial designs and clinical endpoints that promote integral patient selection in a personalized medicine approach. |
Type of Collaborative Activity: |
Meeting/ Workshop
|
Year the Collaborative Activity Originated: |
2021 |
NIH Participating Institutes/Centers/Office of the Director: |
NCI |
HHS Agency Collaborators on this Activity: |
FDA |
